Phase II evaluation of peroral carmofur, cyclophosphamide, and hexamethylmelamine as a second-line therapy in advanced epithelial ovarian carcinoma. - Sipila,P.; Kivinen,S.; Gröhn,P.; Vesala,J.; Heinonen,E. (Gynecol Oncol, 1989)